15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial
A Prospective, Randomized Noninferiority Trial Comparing 15- and 45-minute Pringle Maneuvers During Liver Resection for Oncologic Indications.
1 other identifier
interventional
600
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the safety of two durations of the Pringle maneuver in adults undergoing elective liver resection for malignant tumors. The main questions it aims to answer are: Is the incidence of post-hepatectomy liver failure different between 15-minute and 45-minute Pringle maneuver durations?
- Do the durations differ in operative time or intraoperative blood loss?
- Researchers will compare patients randomized 1:1 to 15 minutes vs 45 minutes of Pringle clamping to see if outcomes are non-inferior between groups. Participants will:
- Undergo standard oncologic hepatectomy with the assigned Pringle duration.
- Receive routine perioperative assessments, including laboratory tests and clinical evaluations.
- Attend follow-up visits at approximately 6 months, 1 year, and 3 years after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2025
CompletedFirst Posted
Study publicly available on registry
November 19, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2030
November 19, 2025
October 1, 2025
2.9 years
November 14, 2025
November 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Posthepatectomy liver failure
Posthepatectomy liver failure defined by the International Study Group of Liver Surgery as a postoperative deterioration of the liver's synthetic, excretory, and detoxifying functions, characterized by an increased INR and concomitant hyperbilirubinemia (per local lab normals) on or after postoperative day 5.
On or after postoperative day 5
Secondary Outcomes (2)
Intraoperative blood loss
At the completion of the surgery
Parenchymal transection time
At the completion of the surgery
Study Arms (2)
15 minute Pringle manouver with 10 minute reperfusion
EXPERIMENTALHepatic pedicle clamping for 15 minutes, followed by a 10-minute declamping period during liver transection.
45 minute Pringle manouver with 15 minute reperfusion
EXPERIMENTALHepatic pedicle clamping for 45 minutes, followed by a 15-minute declamping period during liver transection.
Interventions
The Pringle maneuver involves temporary clamping of the hepatic pedicle during liver resection to reduce blood loss during parenchymal transection.
Eligibility Criteria
You may qualify if:
- Diagnosis of a primary or secondary malignant liver tumor.
- Age \> 18 years.
- Patient deemed eligible for liver resection.
- WHO performance status ≤ 2.
- Ability to provide written informed consent.
You may not qualify if:
- Liver cirrhosis.
- Liver dysfunction classified as Child-Pugh class B or C.
- Repeat hepatectomy.
- Prior ablation or chemoembolization of hepatic lesions.
- Prior portal vein branch embolization.
- Planned or performed ALPPS procedure.
- Concomitant resection of any organ other than the gallbladder during the same operation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of General, Transplant and Liver Surgery, Medical University of Warsaw
Warsaw, 02-091, Poland
Related Publications (6)
Wang HP, Hou TY, Li WF, Yong CC. Inflow control can be safely used in laparoscopic subsegmentectomy of the liver: a single-center 10-year experience. BMC Surg. 2023 Dec 6;23(1):366. doi: 10.1186/s12893-023-02282-2.
PMID: 38057769BACKGROUNDvan den Broek MA, Bloemen JG, Dello SA, van de Poll MC, Olde Damink SW, Dejong CH. Randomized controlled trial analyzing the effect of 15 or 30 min intermittent Pringle maneuver on hepatocellular damage during liver surgery. J Hepatol. 2011 Aug;55(2):337-45. doi: 10.1016/j.jhep.2010.11.024. Epub 2010 Dec 13.
PMID: 21147188BACKGROUNDDoi S, Yasuda S, Hokuto D, Kamitani N, Matsuo Y, Sakata T, Nishiwada S, Nagai M, Nakamura K, Terai T, Kohara Y, Sho M. Impact of the Prolonged Intermittent Pringle Maneuver on Post-Hepatectomy Liver Failure: Comparison of Open and Laparoscopic Approaches. World J Surg. 2023 Dec;47(12):3328-3337. doi: 10.1007/s00268-023-07201-3. Epub 2023 Oct 3.
PMID: 37787778BACKGROUNDLiu J, Wang W, Shi C, Li C, Xue F, Hu L, Wang Y, Ge R. The difference in prolonged continuous and intermittent Pringle maneuver during complex hepatectomy for hepatocellular carcinoma patients with chronic liver disease: A retrospective cohort study. Cancer Med. 2021 Dec;10(23):8507-8517. doi: 10.1002/cam4.4361. Epub 2021 Oct 18.
PMID: 34658153BACKGROUNDFagenson AM, Gleeson EM, Nabi F, Lau KN, Pitt HA. When does a Pringle Maneuver cause harm? HPB (Oxford). 2021 Apr;23(4):587-594. doi: 10.1016/j.hpb.2020.07.014. Epub 2020 Sep 12.
PMID: 32933844BACKGROUNDHuang Y, Liao A, Pu X, Yang J, Lv T, Yan L, Yang J, Wu H, Jiang L. A randomized controlled trial of effect of 15- or 25-minute intermittent Pringle maneuver on hepatectomy for hepatocellular carcinoma. Surgery. 2022 Jun;171(6):1596-1604. doi: 10.1016/j.surg.2021.11.012. Epub 2021 Dec 13.
PMID: 34916072BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emilia Kruk, MD
Medical University of Warsaw
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2025
First Posted
November 19, 2025
Study Start
December 1, 2025
Primary Completion (Estimated)
November 1, 2028
Study Completion (Estimated)
November 1, 2030
Last Updated
November 19, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share
We do not plan to share individual participant data (IPD). The design of this study does not require public IPD sharing for the reliability of the published results. De-identified IPD may be provided to journal peer reviewers under confidentiality during manuscript review.